ISHLT

ISHLT
About Us
Share:
Subscribe:

About Us

The International Society for Heart and Lung Transplantation (ISHLT) is a not-for-profit professional organization with more than 2,700 members from over 45 countries dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies via research, education and advocacy. For more information, visit www.ishlt.org.

Pick a time period -

Tags ( Active)

All Regulatory Non-Regulatory

Current Models Overestimate Survival for Pulmonary Arterial Hypertension (PAH) Patients Awaiting Lung Transplant

Sat, Apr 27, 2013 16:07 CET

Researchers create new equation to gauge patient survival to be presented at International Society for Heart and Lung Transplantation Annual MeetingMONTREAL, April 27, 2013 – The latest research in pulmonary arterial hypertension (PAH) will be revealed today at the International Society for Heart and Lung Transplantation (ISHLT) 33rd Annual Meeting and Scientific Sessions in Montreal, Canada. The study specifically reviewed past and current methods of predicting survival for PAH patients awaiting lung transplant. Results show that current models are overestimating

Sickest Children Not Benefiting from Recent Advances in Heart Transplant Therapy

Thu, Apr 25, 2013 21:04 CET

Research indicates an overall decrease in pediatric waitlist mortality by 44 percentMONTREAL, April 25, 2013 – The latest research on children awaiting heart transplant will be presented today at the International Society for Heart and Lung Transplantation (ISHLT) 33rd Annual Meeting and Scientific Sessions in Montreal, Canada. The study set out to determine if waitlist survival has improved for children (under the age of 18) in the era of greater pediatric ventricular assist device (VAD) utilization using data from the Organ Procurement and Transplant Network (OPTN) (

There are no items matching the current filter

There are no more items matching the current filter

Share

About Us

Current Models Overestimate Survival for Pulmonary Arterial Hypertension (PAH) Patients Awaiting Lung Transplant

Sickest Children Not Benefiting from Recent Advances in Heart Transplant Therapy

Media